Close Menu

glioblastoma

Tempus will provide sequencing and analysis for glioblastoma patients in a clinical trial at Duke using engineered poliovirus as a treatment.

Investigators explored computational strategies for identifying microRNAs that are most relevant to tumor development and progression.

This Week in PNAS

In PNAS this week: link between gene flow restriction and insecticide resistance in malaria mosquitos, cotton leaf shape genetics, and more.

The research team established that its model can be used to determine the optimal dose of radiation therapy for individual patients. 

Dartmouth researchers characterized 5-methylcytosine and 5-hydroxymethylcytosine marks in more than two dozen glioblastoma samples.

Short tandem repeat and expression data indicate that the U87MG cell line in the ATCC collection no longer represents the glioma from which it was established.

The companies will collaborate on clinical trials that utilize Tocagen's investigational treatment and RiboMed's prognostic assay technology.

A team of German researchers identified the four-microRNA signature and said it might inform treatment decisions.

In an analysis of glioblastoma, the researchers identified changes in protein signaling linked to resistance as early as several days after treatment.

ISB President and Co-founder Lee Hood will join Providence as senior VP and chief science officer as the partners join forces on research.

Pages

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

In Science this week: three studies from the Ruminant Genome Project, and more.